Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: A comparison of two surveys with a 5 year interval

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 10, 2010, Pages 2128-2133

  den Heijer, C D J ^a   Donker, G A ^b   Maes, J ^a   Stobberingh, E E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Antibiotic use; Antimicrobial resistance; Community acquired; Cystitis; ESBLs

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; NITROFURANTOIN; NORFLOXACIN; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CHILD; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NONHUMAN; PRACTICE GUIDELINE; PRESCRIPTION; SCHOOL CHILD; URINARY TRACT INFECTION; URINE CULTURE; UROPATHOGENIC ESCHERICHIA COLI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ESCHERICHIA COLI INFECTIONS; FEMALE; GENERAL PRACTICE; GUIDELINE ADHERENCE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NETHERLANDS; TIME FACTORS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; YOUNG ADULT;

EID: 77957229432     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq286     Document Type: Article

References (30)

1. Wiersma TJ, Timmermans AE. [Summary of the 'Urinary tract infections' guideline (first revision) of the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 2001; 145: 735-9.
2. Degener J. NETHMAP 2009: Consumption of Antimicrobial Agents and Antimicrobial Resistance among Important Bacteria in the Netherlands. Amsterdam: SWAB, 2009.
3. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. Euro Surveill 2008; 13: 19-29.
4. van Pinxteren B, van Vliet SM, Wiersma TJ et al. [Summary of the practice guideline 'Urinary-tract infections' (second revision) from the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 2006; 150: 718-22.
5. Nys S, van Merode T, Bartelds AI et al. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 2006; 57: 955-8.
6. Nys S, van Merode T, Bartelds AI et al. Antibiotic treatment and resistance of unselected uropathogens in the elderly. Int J Antimicrob Agents 2006; 27: 236-41.
7. Knottnerus BJ, Nys S, Ter Riet G et al. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother 2008; 62: 356-9.
8. Donker G. Continuous Morbidity Registration at Dutch Sentinel Stations, 2008. Utrecht: Netherlands Institute for Health Services Research (NIVEL), 2010.
9. Schito GC, Naber KG, Botto H et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34: 407-13.
10. Warren JM, Mazzulli T, Moineddin R et al. Uropathogen antibiotic resistance in adult women presenting to family physicians with acute uncomplicated cystitis. Can J Infect Dis Med Microbiol 2004; 15: 266-70.
11. Nys S, Terporten PH, Hoogkamp-Korstanje JA et al. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in the Netherlands (1998-2005). J Antimicrob Chemother 2008; 62: 126-32.
12. Sannes MR, Kuskowski MA, Johnson JR. Geographical distribution of antimicrobial resistance among Escherichia coli causing acute uncomplicated pyelonephritis in the United States. FEMS Immunol Med Microbiol 2004; 42: 213-8.
13. Isenberg HD. Essential Procedures for Clinical Microbiology. Washington, DC: ASM Press, 1998.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
15. EUCAST Definitive Document E. DEF 3.1, June 2000. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infect 2000; 6: 509-15.
16. NVMM. NVMM-richtlijn voor screening en confirmatie van extendedspectrum beta-lactamases (ESBL's) in Enterobacteriaceae. http://www.nvmm.nl/nvmm/nvmmcms.nsf/viewdoc/DC9C2B8FB0A0B7A8C12571FF00 37BED0 (15 April 2010, date last accessed).
17. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO. SENS project. J Antimicrob Chemother 2003; 51: 69-76.
18. De Backer D, Christiaens T, Heytens S et al. Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval. J Antimicrob Chemother 2008; 62: 364-8.
19. EARSS. EARSS annual report 2008. http://www.rivm.nl/earss (23 February 2010, date last accessed).
20. Sturm PD, Bochum ET, Van Mook-Vermulst SV et al. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum β-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Microb Drug Resist 2010; 16: 55-60.
21. Freeman JT, Anderson DJ, Sexton DJ. Seasonal peaks in Escherichia coli infections: possible explanations and implications. Clin Microbiol Infect 2009; 15: 951-3.
22. O'Brien K, Hillier S, Simpson S et al. An observational study of empirical antibiotics for adult women with uncomplicated UTI in general practice. J Antimicrob Chemother 2007; 59: 1200-3.
23. Kunin CM, White LV, Hua TH. A reassessment of the importance of 'low-count' bacteriuria in young women with acute urinary symptoms. Ann Intern Med 1993; 119: 454-60.
24. Stamm WE, Counts GW, Running KR et al. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982; 307: 463-8.
25. European urinalysis guidelines. Scand J Clin Lab Invest Suppl 2000; 60 Suppl 231: 1-96.
26. Naber KG, Schito G, Botto H et al. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54: 1164-75.
27. Clague JE, Horan MA. Urine culture in the elderly: scientifically doubtful and practically useless? Lancet 1994; 344: 1035-6.
28. Nicolle LE. Urinary tract pathogens in complicated infection and in elderly individuals. J Infect Dis 2001; 183 Suppl 1: S5-8.
29. Grover ML, Bracamonte JD, Kanodia AK et al. Urinary tract infection in women over the age of 65: is age alone a marker of complication? J Am Board Fam Med 2009; 22: 266-71.
30. Goettsch W, van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000; 46: 223-8.